Literature DB >> 20159429

Value of brain magnetic resonance imaging in mitochondrial respiratory chain disorders.

Luísa Diogo1, Miguel Cordeiro, Paula Garcia, Isabel Fineza, Cristina Moura, Catarina Resende Oliveira, Margarida Veiga, Teresa Garcia, Manuela Grazina.   

Abstract

Mitochondrial respiratory chain (MRC) disorders have variable clinical manifestations which are mainly neurologic. Diagnosis in children is more complex than in adults because the classic phenotype, ragged red fibers, and mtDNA mutations are rarely seen in children. Moreover, clinical manifestations of disease in developing brains are less explicit. Although not specific, neuroimaging may be contributory to the diagnosis of these disorders in pediatric patients. Brain magnetic resonance images were reviewed for 133 pediatric patients investigated for a MRC disorder at a single center over a period of 10 years (1997-2006), in an attempt to identify distinctive neuroimaging features of MRC defects. Patients fit into four groups, according to the Bernier criteria: definite (63 cases), probable (53 cases), possible (7 cases) and unlikely diagnosis (10 cases). Brain atrophy (41 cases), supratentorial white matter lesions (14 cases), basal ganglia involvement (9 cases), and delayed myelination (9 cases) were the most frequent anomalies in the definite group, and 8 patients presented Leigh syndrome. Neuroimaging findings of the 63 children in the definite group were compared with the remainder and with those in the possible and unlikely groups. There were no significant differences in brain images between the groups analyzed, and therefore no distinctive brain imaging features were identified specific for MRC disorders. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159429     DOI: 10.1016/j.pediatrneurol.2009.09.010

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  5 in total

Review 1.  Mitochondrial genetic diseases.

Authors:  Marni J Falk; Neal Sondheimer
Journal:  Curr Opin Pediatr       Date:  2010-12       Impact factor: 2.856

2.  Design and implementation of the first randomized controlled trial of coenzyme CoQ₁₀ in children with primary mitochondrial diseases.

Authors:  Peter W Stacpoole; Ton J deGrauw; Annette S Feigenbaum; Charles Hoppel; Douglas S Kerr; Shawn E McCandless; Michael V Miles; Brian H Robinson; Peter H Tang
Journal:  Mitochondrion       Date:  2012-09-25       Impact factor: 4.160

3.  New mitochondrial DNA mutations in tRNA associated with three severe encephalopamyopathic phenotypes: neonatal, infantile, and childhood onset.

Authors:  María del Mar O'Callaghan; Sonia Emperador; Ester López-Gallardo; Cristina Jou; Nuria Buján; Raquel Montero; Angels Garcia-Cazorla; Diana Gonzaga; Isidre Ferrer; Paz Briones; Eduardo Ruiz-Pesini; Mercè Pineda; Rafael Artuch; Julio Montoya
Journal:  Neurogenetics       Date:  2012-05-26       Impact factor: 2.660

Review 4.  Neuromitochondrial Disorders : Genomic Basis and an Algorithmic Approach to Imaging Diagnostics.

Authors:  Santhakumar Senthilvelan; Sabarish S Sekar; Chandrasekharan Kesavadas; Bejoy Thomas
Journal:  Clin Neuroradiol       Date:  2021-06-09       Impact factor: 3.649

5.  The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Mauro Scarpelli; Giuseppe Kenneth Ricciardi; Alberto Beltramello; Isabella Zocca; Francesca Calabria; Anna Russignan; Francesca Zappini; Maria Sofia Cotelli; Alessandro Padovani; Giuliano Tomelleri; Massimiliano Filosto; Paola Tonin
Journal:  Neuroradiol J       Date:  2013-11-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.